Ad blocking detected

Thank you for visiting We have detected you cannot see ads being served on our site due to blocking. Unfortunately, due to the high cost of data, we cannot serve the requested page without the accompanied ads.

If you have installed ad-blocking software, please disable it (sometimes a complete uninstall is necessary). Private browsing Firefox users should be able to disable tracking protection while visiting our website. Visit Mozilla support for more information. If you do not believe you have any ad-blocking software on your browser, you may want to try another browser, computer or internet service provider. Alternatively, you may consider the following if you want an ad-free experience.

Canadian Insider Ultra Club
$500/ year*
Daily Morning INK newsletter
+3 months archive
Canadian Market INK weekly newsletter
+3 months archive
30 publication downloads per month from the PDF store
Top 20 Gold, Top 30 Energy, Top 40 Stock downloads from the PDF store
All benefits of basic registration
No 3rd party display ads

* Price is subject to applicable taxes.

Paid subscriptions and memberships are auto-renewing unless cancelled (easily done via the Account Settings Membership Status page after logging in). Once cancelled, a subscription or membership will terminate at the end of the current term.

Covalon Technologies Ltd. (V:COV)

Business Focus: Biotechnology & Medical Research (NEC)

Get the company report for the most recent outlook updated daily

Insider Chart - Past 6 Months

Insider Filings

Latest 10 SEDI filings for COV within the last 6 months
See all filings within the past 6 months

Company News

Sep 19, 2023 07:30 ET
Covalon Showcases Compassionate Pediatric Care Solutions at 47th APHON Conference
Covalon Technologies Ltd. (the “Company” or “Covalon”) (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its participation in the 47th annual Association of Pediatric Hematology/Oncology Nurses (“APHON”) Conference and Exhibit, to be held in Cleveland, Ohio from Thursday, September 21 to Saturday, September 23, 2023. Covalon invites all attendees to booth 425 at the Huntington Convention Center, where they can explore our compassionate infection prevention solutions tailor made for pediatric patients.
Read full article
Aug 16, 2023 07:00 ET
Covalon Announces Third Quarter Fiscal 2023 Results
Covalon Technologies Ltd. (the "Company" or "Covalon") (TSXV: COV; OTCQX: CVALF), an advanced medical technologies company, today announced its third quarter fiscal 2023 results.
Read full article
See more news stories

Valuation Ratios

Price to Sales - TTM
Price to Book - most recent quarter
Price to Cash Flow per share - TTM
Price to Free Cash Flow per share - TTM
See all valuations

Short Report

DateNumber of Shares ShortedNet Change
Sep 15, 20233,5911,087
Aug 31, 20232,504-6,137
Aug 15, 20238,641-2,500
See Short Report

Business Summary

Sector:  Healthcare Industry:  Biotechnology & Medical Research

Covalon Technologies Ltd. is engaged in researching, developing, manufacturing, and marketing of protected medical products that enhance patient outcomes and save lives in the areas of wound care, infection management and surgical procedures. It develops products that are sold under Covalon's name. It also develops and commercializes medical products for other medical companies under development and license contracts. Its dressing types include alginate dressings, antimicrobial dressings, antimicrobial powder burn dressings, collagen dressings, collagen powders diabetic ulcer dressings, foam dressings, hydrocolloid dressings, silicone dressings, and super absorbent dressings. Its perioperative care solutions provide antimicrobial protection of pre-operative skin, through postoperative incision care to scar prophylaxis. Its brands include ColActive Plus, ColActive Plus Powder, ColActive Transfer, CovaClear IV, IV Clear, SurgiClear, VALGuard, CovaWound, CovaView IV and MediClear PreOp.

See business summary



Search (past week) for $COV.CA COV.V

  • No tweets found